Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,104 public trials 1,784 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, not recruiting

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

NCT04437511

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • Gilbert Neurology Gilbert, Arizona, United States
  • Xenoscience Phoenix, Arizona, United States
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Perseverance Research Center Scottsdale, Arizona, United States
View all 274 locations
View Trial Details
Active, not recruiting

PASS of Paediatric Patients Initiating Selumetinib

NCT05388370

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Vienna, Austria
  • Research Site Amiens, France
  • Research Site Angers, France
  • Research Site Bordeaux, France
View all 46 locations
View Trial Details
Active, not recruiting

Preventing Alzheimer's With Cognitive Training

NCT03848312

Conditions
Age-related Cognitive Decline, Alzheimer Disease, Alzheimer's Disease and Related Dementias, +8 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Florida Jacksonville, Florida, United States
  • University of North Florida Jacksonville, Florida, United States
  • The Roskamp Institute Sarasota, Florida, United States
View Trial Details
Active, not recruiting

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

NCT02962414

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
Locations
  • TGen APNNA Phoenix, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • UCSF Benioff Children s Hospital Oakland, California, United States
  • Rady Children s Hospital San Diego, California, United States
View all 67 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)

NCT04849741

Conditions
Alexander Disease, Brain Diseases, Brain Diseases, Metabolic, +13 more
Locations
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • Children's Hospital of Atlanta Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View all 13 locations
View Trial Details
Active, not recruiting

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT05101148

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Rochester, Minnesota, United States
  • Research Site Akron, Ohio, United States
  • Research Site Bydgoszcz, Poland
  • Research Site Gdansk, Poland
View Trial Details

Related conditions